Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030

BRISTOL, Tenn. - Dec. 28, 2020 - PRLog -- Roots Analysis is pleased to announce the publication of its recent study, titled, "Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030"

The report provides a detailed study on the current market landscape and future potential of the companies having the capabilities to manufacture radiopharmaceuticals. In addition, the study features an in-depth analysis, highlighting the capabilities of a diverse set of industry stakeholders. Amongst other elements, the report features the following:

§  A detailed assessment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals.

§  An insightful four-dimensional comparison of the radiopharmaceutical manufacturers.

§  Tabulated profiles of key industry players based in North America, Europe and Asia-Pacific (shortlisted based on the company size of the players).

§  An analysis of recent partnerships and collaborations inked in this domain since 2017.

§  A detailed discussion on the supply chain model of medical isotope Mo-99 (Tc-99m).

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Target Therapeutic Area

§  Cardiology

§  Neurology

§  Oncology

§  Thyroid

§  Others

• Application Area

§  Diagnostic

§  Therapeutic

§  Type of Diagnostic Radiopharmaceuticals

§  PET

§  SPECT

§  Type of Therapeutic Radiopharmaceuticals

§  Alpha Emitters

§  Beta Emitters

§  Others

§  Purpose of Production

§  In-House

§  Outsourcing

• Key Geographical Region

§  North America

§  Europe

§  Asia-Pacific and the Rest of the World

Transcripts of interviews held with the following senior level representatives of stakeholder companies

§  J James Davis, Vice President Quality / R&D, Shertech Laboratories

§  Andreas Fotopoulos, Professor of Nuclear Medicine, University of Ioannina Medical School

§  Jan Pruim, Professor of Medical Imaging / Nuclear Medicine Physician, University Medical Center of Groningen

§  Michael van Dam, Professor, Crump Institute for Molecular Imaging, Molecular & Medical Pharmacology

§  Anonymous, ITM Isotopen Technologien München

For more information please click on the following link:

https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

Other Recent Offerings

1.     High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure Chemistries, 2020-2030 (https://www.rootsanalysis.com/reports/high-energy-chemist...)

2.     Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030

3.     China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030

4.     Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com